Quarterly ResultMay 6, 2026, 06:37 AM
Bio-Techne Q3 Revenue $311.4M, down 2%; GAAP EPS $0.32
AI Summary
Bio-Techne Corporation reported a 2% decline in reported and organic revenue to $311.4 million for the third quarter of fiscal 2026, primarily due to prior-year GMP fast-track orders and timing of large Commercial Supply shipments. GAAP EPS increased significantly to $0.32, while adjusted EPS decreased to $0.53. The company also announced a quarterly cash dividend of $0.08 per share.
Key Highlights
- Q3 FY2026 reported revenue declined 2% to $311.4 million.
- Q3 FY2026 GAAP diluted EPS increased to $0.32 from $0.14.
- Q3 FY2026 adjusted diluted EPS decreased to $0.53 from $0.56.
- Protein Sciences segment net sales were $226.2 million, a 1% decrease.
- Diagnostics and Spatial Biology segment net sales were $85.6 million, a 4% decrease (3% organic growth).
- Board of Directors declared a quarterly cash dividend of $0.08 per share.